Stay updated with breaking news from Toronto Memory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Could a new model of testing and drugs make this brain disease as treatable as Type 2 diabetes? As researchers run tests to find out, neuroscience is divided on what to do for now
The relentless pursuit of detecting Alzheimer's has posed a grueling battle for families and the medical community, but a simple eye scan may help ease that burden.
The relentless pursuit of detecting Alzheimer’s has posed a grueling battle for families and the medical community, but a simple eye scan may help ease that burden.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 17, 2023--
– First Clinical Study of a Central Nervous System-Administered RNAi Therapeutic Showed Rapid and Robust Target Engagement with Sustained Effect Over 6 Months with a Single Dose – – ALN-APP Continues to Demonstrate an Encouraging Clinical Safety and Tolerability Profile – – Multiple-dose Portion of Study, Part B, Being Initiated in Approved Regions –